(R)-5-((4-(Methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)-amino)-3-(piperidin-3-yloxy)picolinonitrile

ID: ALA4860336

PubChem CID: 164618132

Max Phase: Preclinical

Molecular Formula: C17H18F3N7O

Molecular Weight: 393.37

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNc1nc(Nc2cnc(C#N)c(O[C@@H]3CCCNC3)c2)ncc1C(F)(F)F

Standard InChI:  InChI=1S/C17H18F3N7O/c1-22-15-12(17(18,19)20)9-25-16(27-15)26-10-5-14(13(6-21)24-7-10)28-11-3-2-4-23-8-11/h5,7,9,11,23H,2-4,8H2,1H3,(H2,22,25,26,27)/t11-/m1/s1

Standard InChI Key:  BTPZYXQYPWFYBC-LLVKDONJSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   12.5138   -4.7422    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.9306   -4.0323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1089   -4.0278    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.6391   -4.4450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6379   -5.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3501   -5.6776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0639   -5.2682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0611   -4.4414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3483   -4.0320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7764   -5.6757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4876   -5.2660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1967   -5.6739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9074   -5.2649    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9066   -4.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1891   -4.0312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4813   -4.4467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9311   -3.2111    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.3459   -3.2107    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0565   -2.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6141   -4.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3206   -3.6194    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1850   -3.2099    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.8947   -2.7977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6073   -3.2082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3108   -2.7995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3108   -1.9778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6012   -1.5665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8874   -1.9810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  4  2  1  0
  2 17  1  0
  9 18  1  0
 18 19  1  0
 20 21  3  0
 14 20  1  0
 15 22  1  0
 23 22  1  1
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4860336

    ---

Associated Targets(Human)

CHEK1 Tchem Serine/threonine-protein kinase Chk1 (6846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.37Molecular Weight (Monoisotopic): 393.1525AlogP: 2.68#Rotatable Bonds: 5
Polar Surface Area: 107.78Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.65CX Basic pKa: 9.37CX LogP: 1.56CX LogD: 0.13
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.16

References

1. Jin T, Xu L, Wang P, Hu X, Zhang R, Wu Z, Du W, Kan W, Li K, Wang C, Zhou Y, Li J, Liu T..  (2021)  Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile.,  64  (20.0): [PMID:34665631] [10.1021/acs.jmedchem.1c00994]

Source